Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.

2.

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

3.

CAR-T cell therapy for cancer causes 'brain fog,' study shows

4.

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

5.

Cancer research in the US is world class. With the government pulling out, its future is uncertain


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot